Out and About

Dribble for the Cure set for Oct. 15

Now in its 10th year, the event has raised more than $1.2 million for pediatric cancer research and treatment

|
Dribble for the Cure 2016
Don Liebig/ASUCLA

Dribble for the Cure 2016, held at UCLA, raised nearly $200,000 for pediatric cancer research.

UCLA basketball coaches Steve Alford and Cori Close and their teams will lead the 10th annual Dribble for the Cure. The event, which raises funds for pediatric cancer, will be held Oct. 15 at UCLA. Last year’s event raised nearly $200,000 and drew more than 1,000 participants. Organizers hope to shatter that record-breaking attendance and fundraising results this year. 

Among those in attendance  will be former UCLA guard John Vallely, who started for John Wooden’s NCAA championship men’s basketball teams in 1969 and 1970 and was instrumental in bringing Dribble for the Cure to UCLA in 2008. The UCLA Athletics Hall of Famer and his wife, Karen, lost their 12-year-old daughter, Erin, to pediatric cancer in 1992. A decade later, Vallely was diagnosed with non-Hodgkin’s lymphoma.

“I’m so excited for our 10th annual Dribble for the Cure,” said Vallely, a two-time stem cell-bone marrow transplant survivor. “I never could have imagined this event would achieve so much.”

The event opens with a festival beginning at 8:30 a.m. at Drake Stadium. Finish line festivities, including the awarding of individual and team fundraising prizes, will be held in Pauley Pavilion beginning at 11:15 a.m.  The event will also feature autographs and pictures with players, along with food and entertainment. 

To date, Dribble for the Cure has raised more than $1.2 million dollars and attracted more than 6,000 dribblers, who collect pledges and dribble a basketball through a mile-long course through campus. Proceeds support the Pediatric Cancer Research Foundation and the cancer research program at the UCLA Mattel Children’s Hospital.

“Dribble for the Cure has given our patients a lifeline of hope toward finding a cure that will reach all children and adolescents with cancer,” said Dr. Theodore Moore, chief and clinical director of the division of pediatric hematology/oncology at the David Geffen School of Medicine at UCLA, and director of the pediatric blood and marrow transplant program at UCLA. “For 10 years, through our partnership with the Pediatric Cancer Research Foundation, our researchers and clinicians have been able to make great strides in developing new therapies to treat cancer and to make a difference in the quality of life of our patients.”

Media Contact